Investor Atlas

2080 Ventures · Investor research

43 investors focused on Biotech targeting Austria

Compare 43 investors focused on Biotech targeting Austria. Review the selection, investor types and reported focus with 2080 Ventures.

43matching investors
5individual investors
38organizations

What this selection covers

This guide contains 43 distinct directory identities matching target markets: Austria; sectors: Biotech. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Austria” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (32), Angel Investor (5), Corporate Venture Capital (3), Private Equity (3).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

Before pitching for Austria, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 43 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
Amino Collective
Venture CapitalView profile ↗
Ananda Impact Ventures
Venture CapitalView profile ↗
Angular Ventures
Venture CapitalView profile ↗
ArcTern Ventures
Venture CapitalView profile ↗
Ardian
Private EquityView profile ↗
Atlas Venture
Venture CapitalView profile ↗
Atomico
Venture CapitalView profile ↗
Boehringer Ingelheim Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
EQT Ventures
Venture Capital, Family OfficeView profile ↗
Fiddlehead Ventures
Venture CapitalView profile ↗
Firstminute Capital
Venture CapitalView profile ↗
Flashpoint VC
Venture CapitalView profile ↗
FLORA Ventures
Venture CapitalView profile ↗
Forbion Capital Partners
Venture CapitalView profile ↗
Ginkgo Equity
Venture CapitalView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
Great Eagle Holdings
Corporate Venture CapitalView profile ↗
HBM Partners
Private EquityView profile ↗
Henry Stebbins
Angel InvestorView profile ↗
Index Ventures
Venture CapitalView profile ↗
IndieBio
Venture CapitalView profile ↗
Levensohn Venture Partners
Venture CapitalView profile ↗
Matt Sutherland
Angel InvestorView profile ↗
Michael Wieser
Angel InvestorView profile ↗
Mountain Labs
Venture CapitalView profile ↗
MPM Capital
Venture CapitalView profile ↗
Nelli Morgulchik
Angel InvestorView profile ↗
NLC
Venture CapitalView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
OrbiMed
Private EquityView profile ↗
Pear VC
Venture CapitalView profile ↗
Polaris Partners
Venture CapitalView profile ↗
Project A Ventures
Venture CapitalView profile ↗
Right Side Capital Management
Venture CapitalView profile ↗
SEE UP Accelerator
AcceleratorView profile ↗
SV Health Investors
Venture CapitalView profile ↗
Target Global
Venture CapitalView profile ↗
Tensor Ventures
Venture CapitalView profile ↗
Venga Ventures
Venture CapitalView profile ↗
Wellcome Trust
Public FundView profile ↗
Wil Benton
Angel InvestorView profile ↗
Yaya Capital
Venture CapitalView profile ↗
ZAKA VC
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.